Open AccessMP39-10 SERUM INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) WAS A VALUABLE BIOMARKER TO PREDICT THE HIGH GRADE PROSTATE CANCER IN FINAL PATHOLOGY IN PATIENTS WHO HAD LOW TO INTERMEDIATE DISEASE ON BIOPSY.
Author(s) -
Myong Kim,
Myungchan Park,
Jong Won Kim,
Donghyun Lee,
Won Hee Park,
In Gab Jeong,
Cheryn Song,
Jun Hyuk Hong,
ChoungSoo Kim,
Tai Young Ahn,
Hanjong Ahn
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.135
Subject(s) - medicine , prostate cancer , prostatectomy , biomarker , insulin like growth factor , cancer , disease , oncology , prostate , growth factor , gynecology , biochemistry , chemistry , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom